Insulin protects heart against ischemia/reperfusion injury through stimulation of glucose metabolism
Ting-ting LI,Jie XU,Xing-hua QIN,Zuo-xu HOU,Min JIA,Xing ZHANG,Feng GAO
DOI: https://doi.org/10.13191/j.chj.2017.0133
2017-01-01
Abstract:AIM To investigate whether insulin (Ins) protects heart against ischemia/reperfusion (I/R) injury through stimulation of glucose metabolism.METHODS Fifty-four rats were randomly divided into three groups:glucose group (Glu),pyruvate group (Pyr) and palmitate group (PA),each group was randomly divided into Control group,I/R group,I/R + Ins group,six rats in each group.Hearts were subjected to 30 min of myocardial ischemia and 1 h of reperfusion and insulin was intravenously infused at 100 U/L for 1 h,30 min before ischemia in vitro.Hemodynamic parameters (LVDP,± dP/dtmax and CF) were detected by multi-channel physiology recorder,phosphorylation and total levels of Akt were determined by Western blot and cardiac infarct size was evaluated by staining with TTC.RESULTS Compared with those in control,LVDP,± dP/dtmax and CF decreased in Glu,Pyr and PA groups following I/R (P ＜0.01).After insulin treatment,LVDP,± dP/dtmax and CF increased in Glu and Pyr groups (P ＜ 0.05),but LVDP,± dP/dtmax and CF did not change in PA group compared with those in I/R.Infarct size did not change in Glu,Pyr and PA groups compared with that in I/R,infarct size decreased in Glu and Pyr groups (P ＜ 0.01),whereas infarct size in PA group did not decrease after insulin treatment.Western blot showed no obvious difference in t-Akt and p-Akt (Ser473) levels between Glu,Pyr and PA groups.Compared with those in I/R,up-regulated p-Akt (Ser473) was found in Glu,Pyr and PA groups (P ＜ 0.05).Glu group showed a further up-regulated p-Akt (Ser473) (P ＜0.05),whereas p-Akt (Ser473) level was not significantly different between Pyr group and PA group after insulin treatment.CONCLUSION Insulin protects heart against acute myocardial I/R injury through stimulation of glucose metabolism,which validates the concept that stimulating of glucose metabolism is a novel therapy for ischemic heart disease.